Since antibodies targeting CD47 are an emerging field of immune-oncology through the promotion of tumour phagocytosis, it will be of interest to determine the extent to which macrophages are involved in tumour clearance following PIT (Smolle and Pichler, 2017). The gene discussed is CD47; the disease is neoplasm.